western therapy

PreclinicalSmall molecule

JJiangxi Qingfeng Pharmaceutical Co. Ltd.

western therapy is one of 42 small molecule programs targeting Influenza. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

InfluenzaActive, not recruiting

Double-BlindCompleted

InfluenzaPreclinical

Active, not recruiting

Double-BlindPreclinical

Completed

Competition

Competitive Landscape

93 competitors in Influenza

#DrugCompanyPhaseTrials

Influenza Vaccine

Novartis

Phase 3

71 2

FLU Vaccine

GSK

Phase 3

7 3

Inactivated Influenza Vaccine

Sanofi

Phase 3

14 4

Live Attenuated Zoster Vaccine

CChangchun BCHT Biotechnology Co.

Phase 3

12 5

Avigan

AAppili Therapeutics Inc.

Phase 2

6 6

Lagevrio

Merck & Co.

Phase 2

2 7

Relenza

GGlaxo Dba Glaxosmithkline

Phase 3

5 8

Seasonal Influenza Vaccine

Novartis

Phase 3

22 9

VAXIGRIP

GSK

Phase 3

9 10

Dexametasone

UUniversity of Malaya

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Influenza1 trial

A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza

Unknown status·—·N/A·NCT01053533·1,100 enrolled

Herbal Medicine1 trial

A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease

Unknown status·—·N/A·NCT01145664·390 enrolled

Effectiveness1 trial

Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease

Completed·JJiangxi Qingfeng Pharmaceutical Co. Ltd.·N/A·NCT01554930·230 enrolled

Double-blind1 trial

Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study

Completed·CChina Academy of Chinese Medical Sciences·N/A·NCT01769794·288 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for western therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — western therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for western therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Jiangxi Qingfeng Pharmaceutical Co. Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: JJiangxi Qingfeng Pharmaceutical Co. Ltd.

western therapy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Influenza1 trial

Herbal Medicine1 trial

Effectiveness1 trial

Double-blind1 trial

References

Drug Info

Quick Facts

Related News